Physician profile
Robert Coronado
NPI 1376502203
$6,087.48
in general payments reported to CMS, 2019-2025
13 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $825 · 2021: $674 · 2022: $717 · 2023: $1,186 · 2024: $1,080 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,738.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,640.41 | 2021-2025 | Venaseal, Abre, In.Pact Admiral |
| Medtronic Vascular, INC. | $1,500.01 | 2019-2020 | |
| Organogenesis INC. | $391.30 | 2024-2025 | Cygnus Dual, Puraply Wound Matrix, Puraply Franchise |
| Abbott Laboratories | $175.20 | 2019 | |
| Angiodynamics, INC. | $120.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $77.55 | 2019-2020 | |
| Pfizer INC. | $39.53 | 2022-2025 | |
| Boston Scientific Corporation | $37.25 | 2023-2024 | Varithena Administration Pack |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $24.76 | 2019 | |
| Biocompatibles, INC. | $24.53 | 2019 | |
| Merit Medical Systems INC | $22.38 | 2020 | |
| Glaxosmithkline, LLC. | $21.41 | 2025 | Bexsero |
| Smith+Nephew, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coronado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.